Concord Biotech Limited (CONCORDBIO.NS)

INR 1721.9

(-1.11%)

Total Assets Summary of Concord Biotech Limited

  • Concord Biotech Limited's latest annual total assets in 2023 was 17 Billion INR , up 12.33% from previous year.
  • Concord Biotech Limited's latest quarterly total assets in 2024 Q1 was - INR , down -100.0% from previous quarter.
  • Concord Biotech Limited reported annual total assets of 15.13 Billion INR in 2022, up 15.33% from previous year.
  • Concord Biotech Limited reported annual total assets of 13.12 Billion INR in 2021, up 11.01% from previous year.
  • Concord Biotech Limited reported quarterly total assets of 17 Billion INR for 2023 Q4, down 0.0% from previous quarter.
  • Concord Biotech Limited reported quarterly total assets of 17 Billion INR for 2023 FY, up 12.33% from previous quarter.

Annual Total Assets Chart of Concord Biotech Limited (2023 - 2019)

Historical Annual Total Assets of Concord Biotech Limited (2023 - 2019)

Year Total Assets Total Assets Growth
2023 17 Billion INR 12.33%
2022 15.13 Billion INR 15.33%
2021 13.12 Billion INR 11.01%
2020 11.82 Billion INR 25.73%
2019 9.4 Billion INR 0.0%

Peer Total Assets Comparison of Concord Biotech Limited

Name Total Assets Total Assets Difference
Biocon Limited 560.7 Billion INR 96.967%
Blue Jet Healthcare Limited 10.58 Billion INR -60.619%
Dishman Carbogen Amcis Limited 95.81 Billion INR 82.25%
Jubilant Ingrevia Limited 47.31 Billion INR 64.059%
Lyka Labs Limited 1.56 Billion INR -985.159%
Panacea Biotec Limited 12.4 Billion INR -37.079%
Piramal Pharma Limited 153.11 Billion INR 88.893%
SMS Lifesciences India Limited 3.9 Billion INR -335.499%
Supriya Lifescience Limited 9.21 Billion INR -84.611%
Syngene International Limited 61.51 Billion INR 72.353%
TAKE Solutions Limited 881.05 Million INR -1830.32%
Zota Health Care Limited 2.28 Billion INR -644.852%